Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation

Journal of Clinical Pharmacology

Volumn 38, Issue 5, 1998, Pages 402-407

  Wells, Thomas G ^a   Heulitt, Mark J ^a   Taylor, Bonnie J ^a   Fasules, James W ^a   Kearns, Gregory L ^b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; EXTRACORPOREAL OXYGENATION; NEWBORN; NONHUMAN; PHARMACODYNAMICS; STOMACH PH;

EID: 0031954988     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04443.x     Document Type: Article

References (21)

1. Kanto WP: A decade of experience with neonatal extracorporeal membrane oxygenation. J Pediatr 1994;124:335-347.
2. Maki M, Ruuska T, Kuusela A-L, Karikoski-Leo R, Ikonen RS: High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care. Crit Care Med 1993;21:1863-1867.
3. Fontana M, Massironi E, Rossi A, Vaglia P, Gancia GP, Tagliabue P, Principi N: Ranitidine pharmacokinetics in newborn infants. Arch Dis Child 1993;68:602-603.
4. Kelly EJ, Chatfield SL, Brownlee KG, Ng PC, Newell SJ, Dear PRF, Primrose JN: The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child 1993;69:37-39.
5. Rosenthal M, Miller PW: Ranitidine in the newborn. Arch Dis Child 1988;63:88-89.
6. Dodge WF, Jelliffe RW, Zwischenberger JB, Bellanger RA, Hokanson JA, Snodgrass WR: Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. Ther Drug Monit 1994;16:552-559.
7. Blumer JL, Rothstein FC, Kaplan BS, Yamashita TS, Eshelman FN, Myers CM, Reed MD: Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease. J Pediatr 1985;107:301-306.
8. Gomeni R, Gomeni C: AUTOMOD: a polyalgorithm for an integrated analysis of linear pharmacokinetic models. Comput Biol Med 1979;9:38-48.
9. Marquardt DW: An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 1963;11:431-441.
10. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criterion in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
11. Wagner JG: Linear pharmacokinetic equations allowing direct calculation of needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 1976;4:443-467.
12. Winter ME: Basic Clinical Pharmacokinetics. San Francisco: Applied Therapeutics, 1980.
13. Holford NHG, Sheiner LB: Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6:429-453.
14. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34:571-590.
15. Kelly DA: Do H2 receptor antagonists have a therapeutic role in childhood? J Pediatr Gastroenterol Nutr 1994;19:270-276.
16. Anand KJS: Gastric lesions in neonates: effects of stress? Crit Care Med 1993;21:1817-1819.
17. James L, Marshall J, Heulitt M, Wells T, Kearns G: Pharmacokinetics and pharmacodynamics of famotidine in children (abstract). Clin Pharmacol Ther 1995;57:179.
18. Treem WR, Davis PM, Hyams JS: Suppresion of gastric acid secretion by intravenous administration of famotidine in children. J Pediatr 1991;118:812-815.
19. Nagita A, Manago M, Aoki S, Mino M, Suzuki K, Ashida K: Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduodenal ulcers. Ther Drug Monit 1994;16:444-449.
20. Fontana M, Tornaghi R, Petrillo M, Lora E, Porro GB, Principi N: Ranitidine treatment in newborn infants: effects on gastric acidity and serum prolactin levels. J Pediatr Gastroenterol Nutr 1993;16:406-411.
21. Newell SJ, Kelly EJ: Ranitidine in infants (abstract). Arch Dis Child 1993;69:544.